12 results
Phosphate binders - quick reference chart of maximum daily dose. Most patients with CKD will require
Phosphate binders ... require phosphate binding ... agents since they ... are not able to ... Only* #CKD #Nephrology
Key Characteristics of Old and New Potassium-Binding Agents

- Dr. Edgar V. Lerma https://twitter.com/edgarvlermamd

#Potassium #Binding #KBinders #Kayexelate
Agents - Dr. ... #KBinders #Kayexelate ... #Comparison #Table ... #HyperKalemia #Nephrology ... #Agents
Table 22 provides the characteristics of various phosphate-binding agents.
#Pharmacology #Nephrology #Phosphate #Phosphorus #Binders #Comparison #Table #Disadvantages
Table 22 provides ... various phosphate-binding ... agents. ... #Pharmacology #Nephrology ... Phosphate #Phosphorus #Binders
Potassium-Binding Agents to Treat Hyperkalemia
Sodium zirconium cyclosilicate (Lokelma):
 • Mechanism: Preferentially captures K in exchange for
Potassium-Binding ... Agents to Treat ... 10 g QD (adjust dose ... aspiration #Potassium #Binding ... #pharmacology #table
Treatment of Stable Narrow-Complex Tachycardia
Regular Rhythm:
 • Attempt vagal maneuvers
 • Give adenosine 6 milligrams IV
Treatment of Stable ... Repeat 12-milligram dose ... nodal blocking agents ... underlying cause #Stable ... management #cardiology #algorithm
Treatment Algorithm for Active Proliferative Lupus Nephritis (Class III/IV or Mixed Class III/IV + V)
Induction Therapy
Treatment Algorithm ... Therapy (Induction Agent ... plus mod-high dose ... g/d in divided doses ... Nephritis #management #nephrology
Algorithm for Management of Acute and Chronic Hyperkalemia
Acute Hyperkalemia:
 - IV calcium (10 mL of 10%)
Algorithm for Management ... - Consider K+ binders ... titrate to optimal dose ... facilitate RAASi dose ... Chronic #treatment #nephrology
Preoperative Risk Evaluation

Major Pre-Op Questions:
1. Does the patient have any modifiable risk factors that could be
Does the patient ... - Any adverse events ... event, follow ACC algorithm ... Stable patients ... postoperative cardiac events
Myasthenia Gravis - Summary
 • an autoimmune disease of the postsynaptic neuromuscular junction associated with antibodies
serologic, and EMG findings ... characteristic EMG finding ... exacerbation at high doses ... immunosuppressant agents ... diagnosis #management #neurology
Hyperkalemia - Diagnosis and Management - GrepMed Handbook

S/Sx: Most pts asymptomatic. Weakness, cramping, nausea, paresthesias, palpitations,
Elimination (see Table ... Transient, repeat dose ... Treatments: • K-Binding ... Treatment #potassium #nephrology